Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2) 12-month results from a randomised, double-masked, phase 3 trial /

Khanani Arshad M, Patel Sunil S, Staurenghi Giovanni, Tadayoni Ramin, Danzig Carl J, Eichenbaum David A, Hsu Jason, Wykoff Charles C, Heier Jeffrey S, Lally David R, Monés Jordi, Nielsen Jared S, Sheth Veeral S, Kaiser Peter K, Clark Julie, Zhu Liansheng, Patel Hersh, Tang Justin, Desai Dhaval, Jaffe Glenn J, Kollaborációs szervezet: GATHER2 trial investigators, Tóth-Molnár Edit
2023